Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

We aimed to explore the role of antithrombin III (AT-III) activity in diagnosing patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and chronic bronchitis, and its relationship with all-cause mortality of AECOPD patients. We performed univariate and multivariate Cox r...

Full description

Bibliographic Details
Main Authors: Shuling Zhang, Xiaoguang Li, Haili Ma, Mengpei Zhu, Yuequan Zhou, Qianqian Zhang, Hongxing Peng
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:COPD
Subjects:
Online Access:http://dx.doi.org/10.1080/15412555.2022.2106200
_version_ 1797403989030993920
author Shuling Zhang
Xiaoguang Li
Haili Ma
Mengpei Zhu
Yuequan Zhou
Qianqian Zhang
Hongxing Peng
author_facet Shuling Zhang
Xiaoguang Li
Haili Ma
Mengpei Zhu
Yuequan Zhou
Qianqian Zhang
Hongxing Peng
author_sort Shuling Zhang
collection DOAJ
description We aimed to explore the role of antithrombin III (AT-III) activity in diagnosing patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and chronic bronchitis, and its relationship with all-cause mortality of AECOPD patients. We performed univariate and multivariate Cox regression analyses of the factors determining all-cause mortality. We recruited 279 patients with AECOPD and 91 with chronic bronchitis. On admission, patients with AECOPD had lower AT-III activity (80.7 vs. 86.35%, p = 0.002) and higher neutrophil percentages (70.12 vs. 66.40%, p = 0.02) than those with chronic bronchitis. The patients who died were older (78 vs. 73 years, p < 0.001); had higher CRP (39.05 vs. 5.65 mg/L, p < 0.001), D-dimer (1.72 vs. 0.46 mg/L, p < 0.001), FIB (3.56 vs. 3.05 g/L, p = 0.01) levels; and exhibited lower AT-III activity (71.29 vs. 82.94%, p < 0.001) than the survivors. The AT-III area under the receiver operating characteristic curve for predicting COPD all-cause mortality was 0.75 (p < 0.001), optimal cutoff point 79.75%, sensitivity 86.8%, and specificity 57.1%. Multivariate Cox regression analyses showed that increased levels of CRP (HR = 1.005, p = 0.02), D-dimer (HR = 1.17, p = 0.01), WBC count (HR = 1.11, p = 0.002), and reduced AT-III activity (HR = 0.97, p = 0.02) were independent prognostic factors for all-cause mortality. Patients with AT-III ≤ 79.75% were 4.52 times (p = 0.001) more likely to die than those with AT-III > 79.75%. AT-III activity was lower in patients with AECOPD than in those with chronic bronchitis and is potentially useful as an independent predictor of all-cause mortality in patients with AECOPD: reduced AT-III activity and increased CRP and D-dimer levels indicate a higher risk of all-cause mortality.
first_indexed 2024-03-09T02:47:42Z
format Article
id doaj.art-b2c4d3504bb64610ac90ed5475db796c
institution Directory Open Access Journal
issn 1541-2555
1541-2563
language English
last_indexed 2024-03-09T02:47:42Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series COPD
spelling doaj.art-b2c4d3504bb64610ac90ed5475db796c2023-12-05T16:09:50ZengTaylor & Francis GroupCOPD1541-25551541-25632022-12-0119135336410.1080/15412555.2022.21062002106200Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseShuling Zhang0Xiaoguang Li1Haili Ma2Mengpei Zhu3Yuequan Zhou4Qianqian Zhang5Hongxing Peng6Department of Pulmonary and Critical Care Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and TechnologyDepartment of Cardiology, Hubei No.3 People’s Hospital of Jianghan UniversityDepartment of Pulmonary and Critical Care Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and TechnologyDepartment of Geriatrics Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and TechnologyDepartment of Pulmonary and Critical Care Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and TechnologyDepartment of Pulmonary and Critical Care Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and TechnologyDepartment of Pulmonary and Critical Care Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and TechnologyWe aimed to explore the role of antithrombin III (AT-III) activity in diagnosing patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and chronic bronchitis, and its relationship with all-cause mortality of AECOPD patients. We performed univariate and multivariate Cox regression analyses of the factors determining all-cause mortality. We recruited 279 patients with AECOPD and 91 with chronic bronchitis. On admission, patients with AECOPD had lower AT-III activity (80.7 vs. 86.35%, p = 0.002) and higher neutrophil percentages (70.12 vs. 66.40%, p = 0.02) than those with chronic bronchitis. The patients who died were older (78 vs. 73 years, p < 0.001); had higher CRP (39.05 vs. 5.65 mg/L, p < 0.001), D-dimer (1.72 vs. 0.46 mg/L, p < 0.001), FIB (3.56 vs. 3.05 g/L, p = 0.01) levels; and exhibited lower AT-III activity (71.29 vs. 82.94%, p < 0.001) than the survivors. The AT-III area under the receiver operating characteristic curve for predicting COPD all-cause mortality was 0.75 (p < 0.001), optimal cutoff point 79.75%, sensitivity 86.8%, and specificity 57.1%. Multivariate Cox regression analyses showed that increased levels of CRP (HR = 1.005, p = 0.02), D-dimer (HR = 1.17, p = 0.01), WBC count (HR = 1.11, p = 0.002), and reduced AT-III activity (HR = 0.97, p = 0.02) were independent prognostic factors for all-cause mortality. Patients with AT-III ≤ 79.75% were 4.52 times (p = 0.001) more likely to die than those with AT-III > 79.75%. AT-III activity was lower in patients with AECOPD than in those with chronic bronchitis and is potentially useful as an independent predictor of all-cause mortality in patients with AECOPD: reduced AT-III activity and increased CRP and D-dimer levels indicate a higher risk of all-cause mortality.http://dx.doi.org/10.1080/15412555.2022.2106200copdantithrombin iiithrombinmortality
spellingShingle Shuling Zhang
Xiaoguang Li
Haili Ma
Mengpei Zhu
Yuequan Zhou
Qianqian Zhang
Hongxing Peng
Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
COPD
copd
antithrombin iii
thrombin
mortality
title Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_full Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_fullStr Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_full_unstemmed Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_short Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_sort relationship between antithrombin iii activity and mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
topic copd
antithrombin iii
thrombin
mortality
url http://dx.doi.org/10.1080/15412555.2022.2106200
work_keys_str_mv AT shulingzhang relationshipbetweenantithrombiniiiactivityandmortalityinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease
AT xiaoguangli relationshipbetweenantithrombiniiiactivityandmortalityinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease
AT hailima relationshipbetweenantithrombiniiiactivityandmortalityinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease
AT mengpeizhu relationshipbetweenantithrombiniiiactivityandmortalityinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease
AT yuequanzhou relationshipbetweenantithrombiniiiactivityandmortalityinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease
AT qianqianzhang relationshipbetweenantithrombiniiiactivityandmortalityinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease
AT hongxingpeng relationshipbetweenantithrombiniiiactivityandmortalityinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease